The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis.

Osteoarthritis and Rheumatoid Arthritis sound similar but affect joints differently. Learn their early symptoms and treatment ...

High central nervous system pain activation, as measured by functional MRI, predicts treatment response to TNF inhibitors in ...

Anaptys recently announced the intent to separate its biopharma operations from its substantial royalty assets by year-end 2026, enabling investors to align their investment philosophies and portfolio ...

Unlike typical osteoarthritis, where cartilage in joints breaks down, rheumatoid arthritis results from the immune system ...

A new surgically implanted device the size of a lima bean can help control rheumatoid arthritis that isn't responding to ...

An international team of researchers has found more than 40 new areas in DNA that increase the risk of rheumatoid arthritis. The work is the largest genetic study ever carried out, involving nearly 30 ...

"Rheumatoid Arthritis Continues to Challenge Medical Science While Driving Growth in the Global Therapeutics Market"Boston, Oct. 08, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC ...

The global rheumatoid arthritis drugs market was valued at US$31.27 billion in 2024 and is projected to reach US$56.62 billion by 2033, growing at a CAGR of 6.8%. Increased awareness of RA and its ...

"I realized there were a lot of other people across the country doing the same thing I was. So I figured I could connect with ...

Rheumatoid arthritis (RA) may cause inflammation in your eyes, leading to complications such as dry eyes, redness, and floaters, among others. Early treatment may prevent these conditions from ...